Annual EBIT
-$104.25M$38.06M-57.51%
Summary
- Current Value
- As of today, ACLX annual EBIT is -$104.25M, down -57.51% on
- Historical Performance
- ACLX annual EBIT is down -60.48% over the past 3 years, and down -480.00% over the past 5 years
- All-Time High Comparison
- ACLX annual EBIT is currently -480.00% below its historical high of -$17.97M set on
- 3-Year Low Comparison
- ACLX annual EBIT is +44.24% above its 3-year low of -$186.96M reached on an earlier date
- Sector Comparison
- ACLX annual EBIT is higher than 17.47% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$104.25M | -57.5% | -60.5% | -480.0% | -480.0% | |
| Quarterly EBIT | -$61.78M | -83.8% | +34.2% | -579.3% | -579.3% | |
| TTM EBIT | -$242.55M | -249.4% | -41.1% | -2567.2% | -2567.2% | |
| Price | $68.75 | +5.1% | +108.3% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $107.94M | -2.2% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | -$2.00 | -36.3% | -10.2% | -287.9% | -287.9% | |
| Annual EBITDA | -$99.06M | -54.4% | -55.0% | -461.3% | -461.3% | |
| Annual Net Income | -$107.35M | -51.9% | -65.2% | -497.3% | -497.3% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$66.19M | -57.5% | |
| 5Y | -$32.10M | N/A | -224.8% |
| All | -$17.97M | -480.0% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$186.96M | N/A | +44.2% |
| 5Y | -$186.96M | +44.2% | |
| All | -$186.96M | +44.2% |
EBIT History
| Year | Value | Change |
|---|---|---|
| -$104.25M | -57.5% | |
| -$66.19M | +64.6% | |
| -$186.96M | -187.8% |
| Year | Value | Change |
|---|---|---|
| -$64.96M | -102.4% | |
| -$32.10M | -78.6% | |
| -$17.97M | - |
FAQ
What is the current annual EBIT of ACLX?
As of today, ACLX annual EBIT is -$104.25M
What is 1-year change in ACLX annual EBIT?
ACLX annual EBIT is down -57.51% year-over-year
What is 3-year change in ACLX annual EBIT?
ACLX annual EBIT is down -60.48% over the past 3 years
How far is ACLX annual EBIT from its all-time high?
ACLX annual EBIT is currently -480.00% below its historical high of -$17.97M set on December 31, 2019
How does ACLX annual EBIT rank versus sector peers?
ACLX annual EBIT is higher than 17.47% of companies in Healthcare sector
When is ACLX next annual earnings release?
The next annual earnings release for ACLX is on
Quarterly EBIT
-$61.78M$3.05M-5.19%
Summary
- Current Value
- As of today, ACLX quarterly EBIT is -$61.78M, down -5.19% on
- Historical Performance
- ACLX quarterly EBIT is down -83.77% year-over-year, and up +34.19% over the past 3 years
- All-Time High Comparison
- ACLX quarterly EBIT is currently -511.87% below its historical high of $15.00M set on
- 3-Year Low Comparison
- ACLX quarterly EBIT is +10.34% above its 3-year low of -$68.90M reached on
- Sector Comparison
- ACLX quarterly EBIT is higher than 6.26% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$61.78M | -5.2% | -83.8% | +34.2% | -579.3% | |
| Annual EBIT | -$104.25M | – | -57.5% | -60.5% | -480.0% | |
| TTM EBIT | -$242.55M | -13.1% | -249.4% | -41.1% | -2567.2% | |
| Price | $68.75 | -18.2% | +5.1% | +108.3% | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $4.95M | -34.5% | -81.0% | +100.0% | +100.0% | |
| Quarterly EPS | -$0.99 | -5.0% | -105.1% | +53.5% | -263.6% | |
| Quarterly EBITDA | -$59.93M | -5.0% | -85.7% | +35.7% | -571.2% | |
| Quarterly Net Income | -$55.78M | -5.7% | -115.7% | +39.9% | -513.5% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$53.15M | N/A | -16.2% |
| 3Y | $15.00M | -511.9% | |
| 5Y | $15.00M | -511.9% | |
| All | $15.00M | -511.9% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$68.90M | +10.3% | |
| 3Y | -$68.90M | +10.3% | |
| 5Y | -$93.88M | +34.2% | |
| All | -$93.88M | +34.2% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of ACLX?
As of today, ACLX quarterly EBIT is -$61.78M
What is ACLX quarterly EBIT most recent change?
ACLX quarterly EBIT was down -5.19% on September 30, 2025
What is 1-year change in ACLX quarterly EBIT?
ACLX quarterly EBIT is down -83.77% year-over-year
How far is ACLX quarterly EBIT from its all-time high?
ACLX quarterly EBIT is currently -511.87% below its historical high of $15.00M set on December 31, 2023
How does ACLX quarterly EBIT rank versus sector peers?
ACLX quarterly EBIT is higher than 6.26% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
TTM EBIT
-$242.55M$28.16M-13.13%
Summary
- Current Value
- As of today, ACLX TTM EBIT is -$242.55M, down -13.13% on
- Historical Performance
- ACLX TTM EBIT is down -249.40% year-over-year, and down -41.06% over the past 3 years
- All-Time High Comparison
- ACLX TTM EBIT is currently -2567.17% below its historical high of -$9.09M set on
- 3-Year Low Comparison
- ACLX TTM EBIT is at its 3-year low
- Sector Comparison
- ACLX TTM EBIT is higher than 5.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$242.55M | -13.1% | -249.4% | -41.1% | -2567.2% | |
| Annual EBIT | -$104.25M | – | -57.5% | -60.5% | -480.0% | |
| Quarterly EBIT | -$61.78M | -5.2% | -83.8% | +34.2% | -579.3% | |
| Price | $68.75 | -18.2% | +5.1% | +108.3% | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $35.90M | -37.0% | -77.0% | +100.0% | +100.0% | |
| TTM EPS | -$3.92 | -14.8% | -425.5% | +5.1% | -1345.4% | |
| TTM EBITDA | -$235.73M | -13.3% | -261.0% | -38.6% | -2540.0% | |
| TTM Net Income | -$217.90M | -15.9% | -439.1% | -27.9% | -2296.4% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$137.57M | N/A | -76.3% |
| 3Y | -$69.42M | -249.4% | |
| 5Y | -$9.09M | N/A | -2567.2% |
| All | -$9.09M | -2567.2% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$242.55M | at low | |
| 3Y | -$242.55M | at low | |
| 5Y | -$242.55M | at low | |
| All | -$242.55M | at low |
TTM EBIT History
FAQ
What is the current TTM EBIT of ACLX?
As of today, ACLX TTM EBIT is -$242.55M
What is ACLX TTM EBIT most recent change?
ACLX TTM EBIT was down -13.13% on September 30, 2025
What is 1-year change in ACLX TTM EBIT?
ACLX TTM EBIT is down -249.40% year-over-year
How far is ACLX TTM EBIT from its all-time high?
ACLX TTM EBIT is currently -2567.17% below its historical high of -$9.09M set on December 31, 2020
How does ACLX TTM EBIT rank versus sector peers?
ACLX TTM EBIT is higher than 5.90% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
EBIT Formula
EBIT = − −
Data Sources & References
- ACLX Official Website www.arcellx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1786205/000119312525266932/0001193125-25-266932-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1786205/000095017025029150/0000950170-25-029150-index.htm
- ACLX Profile on Yahoo Finance finance.yahoo.com/quote/ACLX
- ACLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aclx